Affordable Care Act (2010)

The ACA included fraud provisions because lawmakers recognized that expanding healthcare coverage without stronger enforcement would invite more waste and abuse.

As coverage grew, so did the opportunity for fraudulent billing against Medicare and Medicaid. The ACA introduced new tools to fight fraud, strengthened enforcement under the False Claims Act, and expanded whistleblower protections.

It also cemented whistleblowers’ role in healthcare reform by showing that safeguarding taxpayer funds and ensuring program integrity are inseparable from improving patient care.

The ACA made two significant changes to the False Claims Act. It narrowed the public disclosure bar, making it easier for whistleblowers to bring cases. It also expanded liability by linking Anti-Kickback Statute violations to the FCA and adding a 60 day overpayment rule.

Key changes:

– The public disclosure bar is no longer jurisdictional
– Whistleblowers no longer need direct knowledge, just independent knowledge that “materially adds”
– AKS violations are explicitly treated as false claims
– Providers must return overpayments within 60 days

The ACA made two key changes to the Anti-Kickback Statute.

First, it tightened the intent standard. The government no longer needs to prove a person knew the specific law or intended to break it.

Second, the ACA created a direct link to the False Claims Act. Any claim that includes items or services “resulting from” an AKS violation is now automatically a false claim under the FCA. This means kickback violations now carry FCA penalties directly, not just criminal charges.

The ACA narrowed the public disclosure bar to make qui tam suits easier for whistleblowers. Before the ACA, courts had no jurisdiction over cases based on publicly disclosed information unless the relator had direct and independent knowledge. The ACA changed this in three ways:

– The government can now waive the bar even when it clearly applies
– Only federal proceedings trigger the bar; state disclosures no longer count
– Relators qualify as original sources with independent knowledge that “materially adds” to public disclosures, not just direct knowledge

The bar is also no longer a jurisdictional hurdle. Courts treat it as a defense, not a reason to dismiss a case automatically.

The ACA strengthened whistleblower protections in several ways. It increased financial incentives for qui tam relators, extended the statute of limitations for certain actions, and narrowed the public disclosure bar. The law also clarified that original source exceptions apply more broadly.

Key expansions:

– Stronger anti-retaliation provisions for employees who report ACA related fraud
– Broader definitions of protected activity, covering more types of disclosures
– Enhanced ability for whistleblowers to bring cases involving overpayments
– Clearer linkage between the Anti-Kickback Statute and the FCA, strengthening qui tam claims

The ACA made whistleblowers central to healthcare enforcement. It also showed that protecting them protects taxpayer funds.

The ACA expanded HHS authority in two major ways. It gave the Secretary broad power to reduce fraud in the health insurance Marketplaces. It also significantly expanded the Office of Inspector General’s civil monetary penalty authorities, adding new categories of punishable conduct.

These included failure to grant OIG timely access to records, making false statements in enrollment applications, failing to report and return overpayments, and making false statements material to fraudulent claims.

Finally, the ACA also gave HHS authority to establish a process for providers to return Medicare overpayments.

The Affordable Care Act widened FCA exposure for contractors and suppliers by targeting the entire payment chain, not just direct billers. The changes closed several loopholes that previously shielded secondary vendors.

– The Act established that knowingly retaining an overpayment for more than 60 days constitutes a false claim, directly impacting suppliers who receive government funds
– It expanded the definition of “claim” to include reimbursements made to contractors managing federal health programs, pulling supply chain vendors into scope
– It narrowed the public disclosure bar, making it easier for whistleblowers to file suits against subcontractors and logistics firms that were historically harder to reach